Repare Therapeutics competitorsClear all

Repare Therapeutics's top competitors include SpringWorks Therapeutics, Agios Pharmaceuticals, Blueprint Medicines and Loxo Oncology.
Discover new suppliers and conduct deeper comparison analysis with Craft for EnterpriseLearn more
Banner background
Repare Therapeutics
Repare Therapeutics
Repare Therapeutics is a company that develops oncology drugs for patients that target specific vulnerabilities of tumor cells.
SpringWorks Therapeutics
SpringWorks Therapeutics
SpringWorks Therapeutics is dedicated to developing innovative potential new treatments for unserved and underserved patient communities.
Agios Pharmaceuticals
Agios Pharmaceuticals
Agios Pharmaceuticals is a biopharmaceutical company discovering and developing therapeutics for cancer metabolism.
Blueprint Medicines
Blueprint Medicines
Blueprint Medicines discovers and develops highly selective kinase inhibitors for patients with genomically defined cancers.
Loxo Oncology
Loxo Oncology
Loxo Oncology is a biopharmaceutical company focused on targeted cancer therapies for genetically-defined patient populations.
Founding Date
Founding Date
2016
Founding Date
2017
Founding Date
2008
Founding Date
2011
Founding Date
2013
Type
Type
Public
Type
Public
Type
Public
Type
Public
Type
Subsidiary
Tags
Locations
Locations
Montréal, CA HQ
Cambridge, US
Locations
Stamford, US HQ
Durham, US
Locations
Cambridge, US HQ
Locations
Cambridge, US HQ
Zug, CH
Cambridge, US
Locations
Stamford, US HQ
Alcobendas, ES
Boulder, US
New York, US
South San Francisco, US
Employees
Employees
102
Employees
568% increase
Employees
53611% increase
Employees
38376% increase
Employees
4133% increase
Valuation ($)
Valuation ($)
904.6 m
Valuation ($)
3 b
Valuation ($)
3 b
Valuation ($)
6 b
Valuation ($)
N/A
Twitter followers
Twitter followers
800
Twitter followers
365
Twitter followers
2.2 k
Twitter followers
2.3 k
Twitter followers
46
Number of tweets (last 30 days)
Number of tweets (last 30 days)
4
Number of tweets (last 30 days)
9
Number of tweets (last 30 days)
14
Number of tweets (last 30 days)
12
Number of tweets (last 30 days)
N/A
Average likes per tweet (last 30 days)
Average likes per tweet (last 30 days)
10.3
Average likes per tweet (last 30 days)
2.6
Average likes per tweet (last 30 days)
9.4
Average likes per tweet (last 30 days)
7.3
Average likes per tweet (last 30 days)
N/A
Percentage of tweets with engagement (last 30 days)
Percentage of tweets with engagement (last 30 days)
100%
Percentage of tweets with engagement (last 30 days)
88.89%
Percentage of tweets with engagement (last 30 days)
100%
Percentage of tweets with engagement (last 30 days)
100%
Percentage of tweets with engagement (last 30 days)
N/A
Alexa Website Rank
Alexa Website Rank
144339
Alexa Website Rank
246458
Alexa Website Rank
288154
Alexa Website Rank
311593
Alexa Website Rank
229097
Employee Rating
Employee Rating
5
Employee Rating
5
Employee Rating
3.9
Employee Rating
3.7
Employee Rating
5

Financial

Revenue (est.)
Revenue (est.)
N/A
Revenue (est.)
$35m (FY, 2020)
Revenue (est.)
$203.2m (FY, 2020)
Revenue (est.)
$793.7m (FY, 2020)
Revenue (est.)
N/A
Cost of goods
Cost of goods
N/A
Cost of goods
N/A
Cost of goods
$2.8m (FY, 2020)
Cost of goods
$425k (FY, 2020)
Cost of goods
N/A
Gross profit
Gross profit
N/A
Gross profit
N/A
Gross profit
$200.4m (FY, 2020)
Gross profit
$793.3m (FY, 2020)
Gross profit
N/A
Net income
Net income
N/A
Net income
($45.6m) (FY, 2020)
Net income
($327.4m) (FY, 2020)
Net income
$313.9m (FY, 2020)
Net income
($148.9m) (FY, 2017)

Funding

Total funding raised
Total funding raised
$ 150.5m
Total funding raised
$ 228m
Total funding raised
N/A
Total funding raised
$ 115m
Total funding raised
$ 57m
For sources of this data, please see the company profile

View company profiles

SpringWorks Therapeutics
HQ
Stamford, US
Employees
56↑ 8% increase

SpringWorks Therapeutics is dedicated to developing innovative potential new treatments for unserved and underserved patient communities.

View company
Agios Pharmaceuticals
HQ
Cambridge, US
Employees
536↑ 11% increase

Agios Pharmaceuticals is a biopharmaceutical company discovering and developing therapeutics for cancer metabolism.

View company
Blueprint Medicines
HQ
Cambridge, US
Employees
383

Blueprint Medicines discovers and develops highly selective kinase inhibitors for patients with genomically defined cancers.

View company
Loxo Oncology
HQ
Stamford, US

Loxo Oncology is a biopharmaceutical company focused on targeted cancer therapies for genetically-defined patient populations.

View company